Cardiovascular Systems (CSII) Tops Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results
May 4, 2022 7:00 AM EDTConference Call Scheduled for Today, May 4, 2022, at 8:00 a.m. CT (9:00 a.m. ET)
Revenues of $56.2 million decreased 4.9% sequentially compared to second quarter this year and decreased 11.1% compared to third quarter last year Fiscal year 22 revenue guidance narrowed to $235 million to $240 million Announced partnership with Innova Vascular, Inc. to develop full line of thrombectomy devices Announced first in-human experience with peripheral everolimus drug-coated balloon Completed first in-human experience with Propel percutaneous ventricular assist deviceST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc.... More
